EUVIMEDEUVIMED entdecken
Crossref

Lipidomic Predictors of Paclitaxel-Induced Peripheral Neuropathy

Yaping Liu iD, Ciao-Sin Chen iD, Nam Nguyen-Hoang, Alla Karnovsky iD, N Lynn Henry iD, Kathleen A Stringer iD, Daniel L Hertz iD

JCO Precision Oncology · 2026-04 · 10 (4)

DOI: 10.1200/po-25-01196 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Precision Oncology, 2026-04. Verfasst von Yaping Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, MI. Hauptthemen laut MEDLINE: Paclitaxel, Peripheral Nervous System Diseases, Lipidomics, Breast Neoplasms. Die Arbeit nennt 61 Literaturangaben. Gefördert von: NCATS NIH HHS, NCI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Taxane-induced peripheral neuropathy (TIPN) is a common, dose-limiting, and often irreversible toxicity that profoundly diminishes patients' long-term quality of life and compromises taxane treatment efficacy. This study aimed to identify and replicate plasma lipidomic biomarkers of TIPN and paclitaxel pharmacokinetics (PK). METHODS This retrospective analysis used data from a prospective cohort of female patients with early-stage breast cancer receiving once weekly paclitaxel. TIPN was assessed pretreatment and once weekly before each infusion using the European Organization for Research and Treatment of Cancer QLQ-CIPN20 sensory subscale (CIPN8). Paclitaxel PK parameters were estimated from blood samples collected within 10 minutes before the end of first infusion (C max ) and 16-24 hours later (T c>0.05 ). Plasma lipidomics were quantified using the end-of-infusion sample. Linear mixed-effects and linear regression models were used to identify lipids associated with TIPN severity and paclitaxel PK, respectively, with a prespecified false discovery rate of 0.05. RESULTS Among 36 patients, lower sphingomyelin (SM 40:1;3O, a random representative of nine correlated lipids), lower lysophosphatidylethanolamine (LPE O-22:1), higher ceramide (Cer 36:0;2O), and higher phosphatidylinositol (PI 34:2) were associated with greater sensory TIPN. Previously reported associations of phosphoethanolamines, triacylglycerols, and phosphatidylglycerols lipid classes with TIPN were not replicated. Reduced levels of seven correlated lipid species from the (lyso)phosphatidylethanolamine and (lyso)phosphatidylcholine classes were associated with higher paclitaxel C max . CONCLUSION End-of-first-infusion lipidomic profiles identified candidate biomarkers associated with TIPN severity and paclitaxel C max . Larger prospective studies are needed to validate these findings and inform the development of lipid-guided personalized treatment strategies that mitigate TIPN and improve long-term outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PaclitaxelPeripheral Nervous System DiseasesLipidomicsBreast NeoplasmsAntineoplastic Agents, PhytogenicHumansFemaleRetrospective StudiesMiddle AgedAgedBiomarkers

Substanzen

PaclitaxelAntineoplastic Agents, PhytogenicBiomarkers

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, MI.
  • Center for Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI.
  • Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI.
  • Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Medical School, Ann Arbor, MI.

ORCID-Profile: Yaping Liu, Ciao-Sin Chen, Alla Karnovsky, N Lynn Henry, Kathleen A Stringer, Daniel L Hertz

Förderung

  • NCATS NIH HHS
  • NCI NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Liu, Y., Chen, C. S., Nguyen-Hoang, N., Karnovsky, A., Henry, N. L., Stringer, K. A., & Hertz, D. L. (2026). Lipidomic Predictors of Paclitaxel-Induced Peripheral Neuropathy. JCO Precision Oncology, 10(4). https://doi.org/10.1200/po-25-01196

Vancouver

Liu Y, Chen CS, Nguyen-Hoang N, Karnovsky A, Henry NL, Stringer KA, et al. Lipidomic Predictors of Paclitaxel-Induced Peripheral Neuropathy. JCO Precision Oncology. 2026;10(4). doi:10.1200/po-25-01196

BibTeX
@article{Liu2026,
  author = {Liu, Yaping and Chen, Ciao-Sin and Nguyen-Hoang, Nam and Karnovsky, Alla and Henry, N Lynn and Stringer, Kathleen A and Hertz, Daniel L},
  title = {Lipidomic Predictors of Paclitaxel-Induced Peripheral Neuropathy},
  journal = {JCO Precision Oncology},
  year = {2026},
  volume = {10},
  number = {4},
  doi = {10.1200/po-25-01196}
}
Kostenlos starten →